Nordion

Last updated
Nordion Inc.
Company type Subsidiary
IndustryHealth Science
Founded1946
(78 years ago)
 (1946)
Headquarters,
Area served
Global
Key people
Kevin Brooks [1]
Products
  • Gamma Technologies
  • Medical Isotopes
Revenue
  • US$244.8 million (2012) [2]
  • (equivalent to $312.04 million in 2022)
Number of employees
~350 (2015) [3]
Parent Sotera Health LLC
Website www.nordion.com

Nordion Inc., a Sotera Health company, is a health science company that provides Cobalt-60 used for sterilization and treatment of disease (radiotherapy).

Contents

Nordion is headquartered in Ottawa, Ontario, Canada, with facilities in Vancouver, British Columbia and Laval, Quebec. Kevin Brooks is the company's CEO. It was acquired by Sotera Health in 2014 for US$805 million (equivalent to $984.96 million in 2022). [4]

History

Founded in 1946, [5] originally the radium sales department of Eldorado Mining and Refining Ltd., the division developed one of the first radiotherapy units that used the radioisotope cobalt-60 to destroy cancerous tumours.

Soon after, the division was given responsibility for selling radioisotopes produced by the newly established Chalk River Nuclear Laboratories, a nuclear research facility at Chalk River, Ontario. As a result, in 1951, Eldorado established a commercial products division (CPD) to manage the isotope business, especially cobalt-60 used in cancer treatment.

In 1952, the federal government created Atomic Energy of Canada Limited (AECL), a Crown corporation. Shortly thereafter, CPD was transferred to AECL, where it remained for the next 40 years and was renamed the radio-chemical division.

In 1988, ownership of the radio-chemical division was transferred from AECL to the Canadian Development Investment Corporation (CDIC). The company assumed a new name, Nordion International Inc. and was later sold to MDS Health Group in 1991.

In 2010, MDS Inc. completed a strategic repositioning which saw the Company divest its MDS Analytical Technologies and MDS Pharma Services businesses. Also in 2010, shareholders of MDS Inc. approved a change of name from MDS Inc. to Nordion Inc. The Company officially changed its name to Nordion Inc. on November 1, 2010. [6]

In July 2013, Nordion completed the divestiture of its Targeted Therapies business to BTG plc. [7] The company is now focused on Nordion and its sterilization technologies and medical isotopes businesses.

The company generated US$244.8 million USD (equivalent to $299.53 million in 2022) in revenues in the 2012 fiscal year, with over 70% of its revenue coming from within North America. [3]

It was acquired by Sotera Health in 2014 for US$805 million (equivalent to $984.96 million in 2022). [4] The company's press release stated that the acquisition created "the only vertically integrated sterilization company in the world." [8]

Nordion sold its Medical Isotopes business in 2018.

Products


Gamma technologies

Customers use Nordion's gamma-sterilization technologies to sterilize medical surgical supplies and devices, as well as certain consumer products, such as food and cosmetics.

Nordion supplies cobalt-60, [2] the isotope that produces the gamma radiation required to destroy harmful micro-organisms.

The company also designs and sells a family of production irradiators.

Locations

The Nordion corporate headquarters are located in Ottawa, Ontario, Canada. The headquarters are the main manufacturing facilities for medical isotopes, used in medical imaging and radiopharmaceuticals, and for cobalt-60 sources and industrial food irradiators.

The Nordion Gamma Centre of Excellence (GCE) is a gamma irradiation research, training, and demonstration facility located in Laval, Quebec, Canada. The GCE is operated in partnership with the University of Quebec's Armand Frappier Institute.

Nordion has an Asia Pacific Sales Office in Hong Kong.

Related Research Articles

A radionuclide (radioactive nuclide, radioisotope or radioactive isotope) is a nuclide that has excess numbers of either neutrons or protons, giving it excess nuclear energy, and making it unstable. This excess energy can be used in one of three ways: emitted from the nucleus as gamma radiation; transferred to one of its electrons to release it as a conversion electron; or used to create and emit a new particle (alpha particle or beta particle) from the nucleus. During those processes, the radionuclide is said to undergo radioactive decay. These emissions are considered ionizing radiation because they are energetic enough to liberate an electron from another atom. The radioactive decay can produce a stable nuclide or will sometimes produce a new unstable radionuclide which may undergo further decay. Radioactive decay is a random process at the level of single atoms: it is impossible to predict when one particular atom will decay. However, for a collection of atoms of a single nuclide the decay rate, and thus the half-life (t1/2) for that collection, can be calculated from their measured decay constants. The range of the half-lives of radioactive atoms has no known limits and spans a time range of over 55 orders of magnitude.

<span class="mw-page-title-main">Sterilization (microbiology)</span> Process that eliminates all biological agents on an object or in a volume

Sterilization refers to any process that removes, kills, or deactivates all forms of life and other biological agents present in or on a specific surface, object, or fluid. Sterilization can be achieved through various means, including heat, chemicals, irradiation, high pressure, and filtration. Sterilization is distinct from disinfection, sanitization, and pasteurization, in that those methods reduce rather than eliminate all forms of life and biological agents present. After sterilization, an object is referred to as being sterile or aseptic.

<span class="mw-page-title-main">TRIUMF</span> Particle physics laboratory in Canada

TRIUMF is Canada's national particle accelerator centre. It is considered Canada's premier physics laboratory, and consistently regarded as one of the world's leading subatomic physics research centres. Owned and operated by a consortium of universities, it is on the south campus of one of its founding members, the University of British Columbia in Vancouver, British Columbia, Canada. It houses the world's largest normal conducting cyclotron, a source of 520 MeV protons, which was named an IEEE Milestone in 2010. Its accelerator-focused activities involve particle physics, nuclear physics, nuclear medicine, materials science, and detector and accelerator development.

Atomic Energy of Canada Limited (AECL) is a Canadian federal Crown corporation and Canada's largest nuclear science and technology laboratory. AECL developed the CANDU reactor technology starting in the 1950s, and in October 2011 licensed this technology to Candu Energy.

<span class="mw-page-title-main">Bruce Nuclear Generating Station</span> Nuclear power station in Ontario, Canada. Largest nuclear power station in Canada

Bruce Nuclear Generating Station is a nuclear power station located on the eastern shore of Lake Huron in Ontario, Canada. It occupies 932 ha of land. The facility derives its name from Bruce Township, the local municipality when the plant was constructed, now Kincardine due to amalgamation. With eight CANDU pressurized heavy-water reactors, it was the world's largest fully operational nuclear generating station by total reactor count and the number of currently operational reactors until 2016, when it was exceeded in nameplate capacity by South Korea's Kori Nuclear Power Plant. The station is the largest employer in Bruce County, with over 4000 workers.

Wilfrid Bennett Lewis, was a Canadian nuclear scientist and administrator, and was centrally involved in the development of the CANDU reactor.

MAPLE, short for the Multipurpose Applied Physics Lattice Experiment, later renamed MDS Medical Isotope Reactors (MMIR), was a dedicated isotope-production facility built by AECL and MDS Nordion. It included two identical reactors, I and II, as well as the isotope-processing facilities necessary to produce a large portion of the world's medical isotopes, especially molybdenum-99, medical cobalt-60, xenon-133, iodine-131 and iodine-125.

Naturally occurring cobalt (27Co) consists of a single stable isotope, 59Co. Twenty-eight radioisotopes have been characterized; the most stable are 60Co with a half-life of 5.2714 years, 57Co, 56Co, and 58Co. All other isotopes have half-lives of less than 18 hours and most of these have half-lives of less than 1 second. This element also has 11 meta states, all of which have half-lives of less than 15 minutes.

The National Research Universal (NRU) reactor was a 135 MW nuclear research reactor built in the Chalk River Laboratories, Ontario, one of Canada’s national science facilities. It was a multipurpose science facility that served three main roles. It generated radionuclides used to treat or diagnose over 20 million people in 80 countries every year. It was the neutron source for the NRC Canadian Neutron Beam Centre: a materials research centre that grew from the Nobel Prize-winning work of Bertram Brockhouse. It was the test bed for Atomic Energy of Canada Limited to develop fuels and materials for the CANDU reactor. At the time of its retirement on March 31, 2018, it was the world's oldest operating nuclear reactor.

<span class="mw-page-title-main">Cobalt-60</span> Radioactive isotope of cobalt

Cobalt-60 (60Co) is a synthetic radioactive isotope of cobalt with a half-life of 5.2714 years. It is produced artificially in nuclear reactors. Deliberate industrial production depends on neutron activation of bulk samples of the monoisotopic and mononuclidic cobalt isotope 59
Co
. Measurable quantities are also produced as a by-product of typical nuclear power plant operation and may be detected externally when leaks occur. In the latter case the incidentally produced 60
Co
is largely the result of multiple stages of neutron activation of iron isotopes in the reactor's steel structures via the creation of its 59
Co
precursor. The simplest case of the latter would result from the activation of 58
Fe
. 60
Co
undergoes beta decay to the stable isotope nickel-60. The activated cobalt nucleus emits two gamma rays with energies of 1.17 and 1.33 MeV, hence the overall equation of the nuclear reaction is: 59
27
Co
+ n → 60
27
Co
60
28
Ni
+ e + 2 γ

Radionuclides which emit gamma radiation are valuable in a range of different industrial, scientific and medical technologies. This article lists some common gamma-emitting radionuclides of technological importance, and their properties.

Iodine-125 (125I) is a radioisotope of iodine which has uses in biological assays, nuclear medicine imaging and in radiation therapy as brachytherapy to treat a number of conditions, including prostate cancer, uveal melanomas, and brain tumors. It is the second longest-lived radioisotope of iodine, after iodine-129.

<span class="mw-page-title-main">Technetium-99m</span> Metastable nuclear isomer of technetium-99

Technetium-99m (99mTc) is a metastable nuclear isomer of technetium-99, symbolized as 99mTc, that is used in tens of millions of medical diagnostic procedures annually, making it the most commonly used medical radioisotope in the world.

<span class="mw-page-title-main">Cobalt therapy</span> Medical use of gamma rays

Cobalt therapy is the medical use of gamma rays from the radioisotope cobalt-60 to treat conditions such as cancer. Beginning in the 1950s, cobalt-60 was widely used in external beam radiotherapy (teletherapy) machines, which produced a beam of gamma rays which was directed into the patient's body to kill tumor tissue. Because these "cobalt machines" were expensive and required specialist support, they were often housed in cobalt units. Cobalt therapy was a revolutionary advance in radiotherapy in the post-World War II period but is now being replaced by other technologies such as linear accelerators.

<span class="mw-page-title-main">Gold-198</span> Isotope of Gold

Gold-198 (198Au) is a radioactive isotope of gold. It undergoes beta decay to stable 198Hg with a half-life of 2.69464 days.

<span class="mw-page-title-main">Nuclear industry in Canada</span>

Nuclear industry in Canada is an active business and research sector, producing about 15% of its electricity in nuclear power plants of domestic design. Canada is the world's largest exporter of uranium, and has the world's second largest proven reserves. Canada also exports nuclear technology within the terms of the Nuclear Non-proliferation Treaty, to which it is a signatory, and is the world's largest producer of radioactive medical isotopes.

<span class="mw-page-title-main">Samut Prakan radiation accident</span> 2000 radiation accident in Thailand

A radiation accident occurred in Samut Prakan Province, Thailand in January–February 2000. The accident happened when an insecurely stored unlicensed cobalt-60 radiation source was recovered by scrap metal collectors who, together with a scrapyard worker, subsequently dismantled the container, unknowingly exposing themselves and others nearby to ionizing radiation. Over the following weeks, those exposed developed symptoms of radiation sickness and eventually sought medical attention. The Office of Atomic Energy for Peace (OAEP), Thailand's nuclear regulatory agency, was notified when doctors came to suspect radiation injury, some 17 days after the initial exposure. The OAEP sent an emergency response team to locate and contain the radiation source, which was estimated to have an activity of 15.7 terabecquerels (420 Ci), and was eventually traced to its owner. Investigations found failure to ensure secure storage of the radiation source to be the root cause of the accident, which resulted in ten people being hospitalized for radiation injury, three of whom died, as well as the potentially significant exposure of 1,872 people.

<span class="mw-page-title-main">Radioactive source</span>

A radioactive source is a known quantity of a radionuclide which emits ionizing radiation, typically one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.

<span class="mw-page-title-main">Philippine Nuclear Research Institute</span> Agency of the Philippine government

The Philippine Nuclear Research Institute (PNRI) is a government agency under the Department of Science and Technology mandated to undertake research and development activities in the peaceful uses of nuclear energy, institute regulations on the said uses, and carry out the enforcement of said regulations to protect the health and safety of radiation workers and the general public.

References

  1. "Leadership Team". Nordion. n.d. Archived from the original on 6 September 2021. Retrieved 28 December 2021.
  2. 1 2 "2012 Annual Report" (PDF). p. 42. Archived from the original (PDF) on 28 May 2013. Retrieved 27 December 2021.
  3. 1 2 "Nordion Corporate Presentation".
  4. 1 2 Stynes, Tess (2 June 2014). "Nordion Agrees to Sweetened Offer from Sterigenics" . The Wall Street Journal . ISSN   0099-9660. OCLC   781541372. Archived from the original on 11 June 2016. Retrieved 28 December 2021.
  5. "About Nordion". nordion.com. Nordion. Retrieved May 20, 2016.
  6. John, Vita (6 August 2014). "Sterigenics International Completes $826 Million Acquisition of Nordion Inc". Sterigenics International LLC (Press release). Archived from the original on 10 August 2014. Retrieved 28 December 2021 via Business Wire.

Official website OOjs UI icon edit-ltr-progressive.svg